Mobility endpoints in marketing authorisation of drugs: what gets the European medicines agency moving?

BACKGROUND: Mobility is defined as the ability to independently move around the environment and is a key contributor to quality of life, especially in older age. The aim of this study was to evaluate the use of mobility as a decisive outcome for the marketing authorisation of drugs by the European M...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaeger, Simon U, Wohlrab, Martin, Schoene, Daniel, Tremmel, Roman, Chambers, Michael, Leocani, Letizia, Corriol-Rohou, Solange, Klenk, Jochen, Sharrack, Basil, Garcia-Aymerich, Judith, Rochester, Lynn, Maetzler, Walter, Puhan, Milo, Schwab, Matthias, Becker, Clemens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789320/
https://www.ncbi.nlm.nih.gov/pubmed/35077553
http://dx.doi.org/10.1093/ageing/afab242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789320/
https://www.ncbi.nlm.nih.gov/pubmed/35077553
http://dx.doi.org/10.1093/ageing/afab242

Ejemplares similares